Back to AL Alphabet Inc.

QNCXQNCX

Showing 7 of 27 quarters

Position history for ALAlphabet Inc.'s holdings in QUINCE THERAPEUTICS INC

No. Alphabet exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 189,122 shares worth $633,559. Alphabet already held QNCX in its Q3 2019 13F, the earliest on record, and held it in 26 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$147,515

Total Shares Change

-189,122

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$20.20
0
2025-Q4
Unchanged
189,122
0.0%
$633,5590.0%$670.00
0
2025-Q3
Unchanged
189,122
0.0%
$308,2690.0%$326.00
0
2025-Q2
Unchanged
189,122
0.0%
$312,0510.0%$330.00
0
2025-Q1
Unchanged
189,122
0.0%
$251,5320.0%$266.00
0
2024-Q4
Unchanged
189,122
0.0%
$353,6580.0%$374.00
0
2024-Q3
Unchanged
189,122
0.0%
$147,5150.0%$155.20
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used